|
GTF2H2C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.111600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.804400E-02 |
| Normal-vs-Stage2 |
3.027000E-01 |
| Normal-vs-Stage3 |
8.445600E-02 |
| Normal-vs-Stage4 |
4.990100E-02 |
| Stage1-vs-Stage2 |
7.047400E-01 |
| Stage1-vs-Stage3 |
7.682400E-01 |
| Stage1-vs-Stage4 |
5.005200E-01 |
| Stage2-vs-Stage3 |
5.730200E-01 |
| Stage2-vs-Stage4 |
3.342000E-01 |
| Stage3-vs-Stage4 |
6.320200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.686350E-01 |
| Normal-vs-AfricanAmerican |
3.480100E-02 |
| Normal-vs-Asian |
2.683200E-01 |
| Caucasian-vs-AfricanAmerican |
3.266200E-01 |
| Caucasian-vs-Asian |
7.295600E-01 |
| AfricanAmerican-vs-Asian |
9.920400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.618000E-02 |
| Normal-vs-Female |
3.072000E-01 |
| Male-vs-Female |
3.837200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.312000E-02 |
| Normal-vs-Extreme_Weight |
5.277900E-02 |
| Normal-vs-Obese |
1.351980E-01 |
| Normal-vs-Extreme_Obese |
8.472200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.517200E-01 |
| Normal_Weight-vs-Obese |
4.046200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.422200E-01 |
| Extreme_Weight-vs-Obese |
5.538400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.002000E-01 |
| Obese-vs-Extreme_Obese |
5.587000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.502390E-01 |
| Normal-vs-Age(41-60Yrs) |
3.585000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.652200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.394000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.069800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.852000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.876000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.944200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.918400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.432800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.493770E-01 |
| Normal-VS-Type2 PRCC |
6.500100E-02 |
| Normal-VS-KIRP CIMP |
4.798600E-03 |
| Normal-VS-Unclassified PRCC |
8.639200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.232000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.829800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.387200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.439950E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.508400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.539400E-03 |
| Normal-vs-N1 |
1.707000E-01 |
| Normal-vs-N2 |
2.358800E-01 |
| N0-vs-N1 |
3.116600E-01 |
| N0-vs-N2 |
9.084000E-01 |
| N1-vs-N2 |
5.941000E-01 |
|
|
